A phase I/II open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in subjects with relapsed, refractory hematologic malignancies Meeting Abstract
| Authors: | Borthakur, G.; Dawson, M. A.; Stein, E. M.; Karadimitris, A.; Huntly, B. J. P.; Dickinson, M. J.; Chaidos, A.; Horner, T.; Brennan, J.; Baron, J.; Kremer, B. E.; Dhar, A. |
| Abstract Title: | A phase I/II open-label, dose escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in subjects with relapsed, refractory hematologic malignancies |
| Meeting Title: | 58th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 128 |
| Issue: | 22 |
| Meeting Dates: | 2016 Dec 3-6 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2016-12-02 |
| Language: | English |
| ACCESSION: | WOS:000394452702200 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V128.22.5223.5223 |
| Notes: | Meeting Abstract: 5223 -- Source: Wos |
